Effects of Lactobacillus casei NCU011054 on immune response and gut microbiota of cyclophosphamide induced immunosuppression mice
Food and Chemical Toxicology · 2023
DOI: 10.1016/j.fct.2023.113662 ↗Kurz gefasst
Fachartikel in der Zeitschrift Food and Chemical Toxicology, 2023. Verfasst von Fangfang Min und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Food Science and Technology, China-Canada Joint Lab of Food Science and Technology (Nanchang), Key Laboratory of Bioactive Po…. Hauptthemen laut MEDLINE: Lacticaseibacillus casei, Gastrointestinal Microbiome, Intestinal Diseases. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Jiangxi Provincial Department of Science and Technology.
Abstract (Originalsprache)
Lactobacillus (L.) casei NCU011054 isolated from infant feces has been proven to be a potential probiotic in vitro. The present study aimed to investigate the effects of L. casei NCU011054 on the immune response and gut microbiota in cyclophosphamide (CP)-induced immunosuppression mice. Results indicated that L. casei NCU011054 could increase the levels of mucin (Muc2) and tight junction proteins (ZO-1, occludin and claudin-1). Moreover, L. casei NCU011054 was found to upregulate TLRs/NF-κB pathway (TLR-2, TLR-4, TLR-6, p65 and NF-κB) and two transcription factors (T-bet and GATA-3) mRNA levels, and enhance the number of CD4+T cells. Th1-related cytokines (IL-12p70, IFN-γ and TNF-α) and Th2-related cytokines (IL-2, IL-4, IL-6 and IL-10) significantly increased after L. casei NCU011054 treatment. More importantly, L. casei NCU011054 increased the ratio of T-bet to GATA-3 and IFN-γ to IL-4. Apart from these, L. casei NCU011054 remodeled gut microbiota and modulated gut metabolites in CP-induced immunosuppressed mice. The correlation analysis showed that Lactobacillus upregulated by L. casei NCU011054 was positively correlated with TLRs/NF-κB pathway, and the ratio of T-bet to GATA-3 and IFN-γ to IL-4. All findings revealed that L. casei NCU011054 could improve intestinal immune dysfunction and modulate Th1/Th2 balance via TLRs/NF-κB pathway in CP-induced immunosuppressed mice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Food Science and Technology, China-Canada Joint Lab of Food Science and Technology (Nanchang), Key Laboratory of Bioactive Polysaccharides of Jiangxi Province, Nanchang University, 235 Nanjing Ea…
- International Institute of Food Innovation, Nanchang University, Xiaolan Economic and Technological Development Zone, Luozhu Road, Nanchang, 330052, China.
- Institute of Development and Research, Jiangxi General Institute of Testing and Certification, 171 Beijing East Road, Nanchang, 330029, China.
Förderung
- National Natural Science Foundation of China
- Jiangxi Provincial Department of Science and Technology
Zitieren
APA
Min, F., Hu, J., Huang, T., Huang, Y., Nie, S., Xiong, T., & Xie, M. (2023). Effects of Lactobacillus casei NCU011054 on immune response and gut microbiota of cyclophosphamide induced immunosuppression mice. Food and Chemical Toxicology. https://doi.org/10.1016/j.fct.2023.113662
Vancouver
Min F, Hu J, Huang T, Huang Y, Nie S, Xiong T, et al. Effects of Lactobacillus casei NCU011054 on immune response and gut microbiota of cyclophosphamide induced immunosuppression mice. Food and Chemical Toxicology. 2023. doi:10.1016/j.fct.2023.113662
BibTeX
@article{Min2023,
author = {Min, Fangfang and Hu, Jielun and Huang, Tao and Huang, Yousheng and Nie, Shaoping and Xiong, Tao and Xie, Mingyong},
title = {Effects of Lactobacillus casei NCU011054 on immune response and gut microbiota of cyclophosphamide induced immunosuppression mice},
journal = {Food and Chemical Toxicology},
year = {2023},
doi = {10.1016/j.fct.2023.113662}
}
EUVIMED